Clinical Trial

Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita

Study acronym: EMOTI
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this clinical trial is to compare the efficacy and safety of emodepside with the standard treatment, albendazole, in adolescents (12 years and older) and adults infected with Trichuris incognita.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-09-15 -> 2027-01-15 2026-08-15
minor Completion pushed: 2026-09-15 -> 2027-02-15 2026-08-15
Trial Details
NCT Number NCT07258173
Lead Sponsor Jennifer Keiser
Collaborators: Centre Suisse de Recherches Scientifiques en Cote d'Ivoire, Université Félix Houphouët-Boigny, Bayer
Conditions Trichuris Infection
Enrollment 100 participants
Start Date 2026-11-15
Primary Completion 2027-01-15 (estimated)
Study Completion 2027-02-15 (estimated)
Updated on ClinicalTrials.gov 2026-08-14